High materiality7/10
Neogenomics (NEO) PT Raised to $22 at Needham
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Target raised to $22; Current price $19.13.
- Target $22; Price $19.13; Upgrade by Needham.
Key facts
- 01
Target: $22
- 02
Posted price: $19.13
- 03
Analyst firm: Needham
- 04
Analyst: Mike Matson
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.